Nexalin Technology, Inc (NXL)
0.50
-0.04 (7.41%)
Upcoming Events
Latest Headlines
Nexalin Technology receives U.S. patent for neurostimulation method
June 4, 2026 10:01 AM - StreetInsider
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
June 4, 2026 10:00 AM - StreetInsider
Nexalin Technology gains House support for VA neurostimulation research
May 21, 2026 8:33 AM - StreetInsider
Nexalin Technology secures neurostimulation research language in House bill
May 21, 2026 8:31 AM - StreetInsider
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of
May 21, 2026 8:30 AM - Globe NewsWire
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Vete
May 21, 2026 8:30 AM - StreetInsider
Form 8-K Nexalin Technology, Inc. For: May 14
May 19, 2026 4:00 PM - SEC Filing
Nexalin acquires digital health platform for $1.3 million ahead of trial
May 19, 2026 8:30 AM - StreetInsider
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
May 19, 2026 8:30 AM - Globe NewsWire
Form 10-Q Nexalin Technology, Inc. For: Mar 31
May 8, 2026 2:35 PM - SEC Filing
Nexalin reports study shows brain stimulation device improved chronic insomnia
April 28, 2026 9:15 AM - StreetInsider
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
April 28, 2026 9:15 AM - Globe NewsWire
Form 8-K Nexalin Technology, Inc. For: Apr 17
April 22, 2026 4:31 PM - SEC Filing
Nexalin Technology plans pivotal trial for insomnia device
April 22, 2026 9:35 AM - StreetInsider
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
April 22, 2026 9:35 AM - StreetInsider
RedChip's Biotech Investor Conference Replays Now Available
April 20, 2026 8:04 AM - StreetInsider
Nexalin advances Alzheimer's FDA strategy after meetings in US and China
April 15, 2026 10:00 AM - StreetInsider
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
April 15, 2026 10:00 AM - StreetInsider
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
April 14, 2026 8:30 AM - Globe NewsWire
Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
April 9, 2026 7:47 AM - Globe NewsWire
Nexalin Technology Inc. (NXL) PT Lowered to $2 at Maxim Group
April 7, 2026 9:27 AM - StreetInsider
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
April 2, 2026 8:46 AM - StreetInsider
Form 10-K Nexalin Technology, Inc. For: Dec 31
March 25, 2026 11:56 AM - SEC Filing
Full Article List
